Monzon v. Abbott Laboratories
Plaintiff: Monzon and Randi Monzon
Defendant: Abbott Laboratories
Case Number: ILS/3:21-CV-01703
Filed: December 17, 2021
Court: Judicial Panel on Multidistrict Litigation
Presiding Judge: Staci M Yandle
Nature of Suit: Other
RSS RSS Track this Docket
Docket Report

This docket was last retrieved on January 27, 2022. A more recent docket listing may be available from PACER.

Date Filed Document Text
January 27, 2022 Filing 7 ERRATA - to (5 in CAC/2:21-cv-09932, 5 in CAC/5:21-cv-00481, 5 in CAC/5:21-cv-02145, 5 in CAC/5:21-cv-02146, 7 in CT/3:20-cv-01626, 6 in DC/1:20-cv-02537, 7 in FLM/6:21-cv-00502, 7 in FLN/1:21-cv-00201, 7 in ILN/1:22-cv-00071, 5 in ILN/1:22-cv-00192, 5 in ILN/1:22-cv-00197, 5 in ILN/1:22-cv-00203, 5 in ILN/1:22-cv-00204, 6 in ILN/1:22-cv-00232, 5 in ILN/1:22-cv-00239, 5 in ILS/3:21-cv-01703, 6 in LAM/3:21-cv-00687, 19 in MDL No. 3026, 1 in MOW/4:22-cv-00032, 1 in MOW/4:22-cv-00033) - Filed by Defendants Abbott Laboratories, Inc., Abbott Laboratories. (Attachments: #1 Exhibit Proof of Service) Associated Cases: MDL No. 3026, CAC/2:21-cv-09932, CAC/5:21-cv-00481, CAC/5:21-cv-02145, CAC/5:21-cv-02146, CT/3:20-cv-01626, DC/1:20-cv-02537, FLM/6:21-cv-00502, FLN/1:21-cv-00201, ILN/1:22-cv-00071, ILN/1:22-cv-00192, ILN/1:22-cv-00197, ILN/1:22-cv-00203, ILN/1:22-cv-00204, ILN/1:22-cv-00232, ILN/1:22-cv-00239, ILS/3:21-cv-01703, LAM/3:21-cv-00687, MOW/4:22-cv-00032, MOW/4:22-cv-00033 (Feder, Meir) DELETED DUPLICATE PARTY NAMES Modified on 1/28/2022 (CMD).
January 27, 2022 Filing 6 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 1 in MDL No. 3026) -- Identifying Corporate Parent Abbott Laboratories for Abbott Laboratories, Inc.. (Attachments: #1 Exhibit Schedule of Actions, #2 Exhibit Proof of Service) Associated Cases: MDL No. 3026, CAC/2:21-cv-09932, CAC/5:21-cv-00481, CAC/5:21-cv-02145, CAC/5:21-cv-02146, CT/3:20-cv-01626, DC/1:20-cv-02537, FLM/6:21-cv-00502, FLN/1:21-cv-00201, ILN/1:22-cv-00071, ILN/1:22-cv-00192, ILN/1:22-cv-00197, ILN/1:22-cv-00203, ILN/1:22-cv-00204, ILN/1:22-cv-00232, ILN/1:22-cv-00239, ILS/3:21-cv-01703, LAM/3:21-cv-00687, MOW/4:22-cv-00032, MOW/4:22-cv-00033 (Feder, Meir) DELETED DUPLICATE PARTY NAME Modified on 1/27/2022 (CMD).
January 27, 2022 Filing 5 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 1 in MDL No. 3026) -- Identifying Corporate Parent No Parent Corp. for Abbott Laboratories. (Attachments: #1 Exhibit Schedule of Actions, #2 Exhibit Proof of Service) Associated Cases: MDL No. 3026, CAC/2:21-cv-09932, CAC/5:21-cv-00481, CAC/5:21-cv-02145, CAC/5:21-cv-02146, CT/3:20-cv-01626, DC/1:20-cv-02537, FLM/6:21-cv-00502, FLN/1:21-cv-00201, ILN/1:22-cv-00071, ILN/1:22-cv-00192, ILN/1:22-cv-00197, ILN/1:22-cv-00203, ILN/1:22-cv-00204, ILN/1:22-cv-00232, ILN/1:22-cv-00239, ILS/3:21-cv-01703, LAM/3:21-cv-00687, MOW/4:22-cv-00032, MOW/4:22-cv-00033 (Feder, Meir) EDITED CORP. PARENT & DELETED DUPLICATE PARTY NAME Modified on 1/27/2022 (CMD).
January 24, 2022 Filing 4 NOTICE OF APPEARANCE (CORRECTED) re: pldg.( 1 in MDL No. 3026, 13 in MDL No. 3026) Filed by Meir Feder on behalf of Defendants Abbott Laboratories, Inc., #et al.Abbott Laboratories. #[Suppress List] (Attachments: #1 Exhibit Schedule of Actions, #2 Exhibit Proof of Service) Associated Cases: MDL No. 3026, CAC/2:21-cv-09932, CAC/5:21-cv-00481, CAC/5:21-cv-02145, CAC/5:21-cv-02146, CT/3:20-cv-01626, DC/1:20-cv-02537, FLM/6:21-cv-00502, FLN/1:21-cv-00201, ILN/1:22-cv-00071, ILN/1:22-cv-00192, ILN/1:22-cv-00197, ILN/1:22-cv-00203, ILN/1:22-cv-00204, ILN/1:22-cv-00232, ILN/1:22-cv-00239, ILS/3:21-cv-01703, LAM/3:21-cv-00687 (Feder, Meir) EDITED EVENT TYPE, ADDED MDL LINK 13 AND DELETED DUPLICATE PARTY NAMES Modified on 1/25/2022 (CMD).
January 24, 2022 Filing 3 SEE CORRECTED PLDG. 14 NOTICE OF APPEARANCE re: pldg.( 1 in MDL No. 3026) Filed by Meir Feder on behalf of Defendants Abbott Laboratories, Inc., #et al.Abbott Laboratories. #[Suppress List] (Attachments: #1 Exhibit Schedule of Actions, #2 Exhibit Proof of Service) Associated Cases: MDL No. 3026, CAC/2:21-cv-09932, CAC/5:21-cv-00481, CAC/5:21-cv-02145, CAC/5:21-cv-02146, CT/3:20-cv-01626, DC/1:20-cv-02537, FLM/6:21-cv-00502, FLN/1:21-cv-00201, ILN/1:22-cv-00071, ILN/1:22-cv-00192, ILN/1:22-cv-00197, ILN/1:22-cv-00203, ILN/1:22-cv-00204, ILN/1:22-cv-00232, ILN/1:22-cv-00239, ILS/3:21-cv-01703, LAM/3:21-cv-00687 (Feder, Meir) Modified on 1/25/2022 (CMD).
January 19, 2022 Filing 2 ***TEXT ONLY NOTICE***NOTICE OF FILING AND PUBLICATION OF BRIEFING SCHEDULE re: pldg. ( #1 in MDL No. 3026), ( #2 in MDL No. 3026) BRIEFING SCHEDULE IS SET AS FOLLOWS: Notices of Appearance due on or before 2/2/2022. Corporate Disclosure Statements due on or before 2/2/2022. Responses due on or before 2/9/2022. Reply, if any, due on or before 2/16/2022. In their briefs, the parties should address what steps they have taken to pursue alternatives to centralization (including, but not limited to, engaging in informal coordination of discovery and scheduling, and seeking Section 1404 transfer of one or more of the subject cases). #Appearance forms (JPML form 18) and #Corporate Disclosure forms can be downloaded from our website. Important: A Corporate Disclosure Form, if required, must be filed, even if one has previously been filed in this MDL.Please visit the #CM/ECF Filing Guidelines & Forms page of our website for additional information.Signed by Clerk of the Panel John W. Nichols on 1/19/2022. Associated Cases: MDL No. 3026, CAC/2:21-cv-09932, CAC/5:21-cv-00481, CAC/5:21-cv-02145, CAC/5:21-cv-02146, CT/3:20-cv-01626, DC/1:20-cv-02537, FLM/6:21-cv-00502, FLN/1:21-cv-00201, ILN/1:22-cv-00071, ILN/1:22-cv-00192, ILN/1:22-cv-00197, ILN/1:22-cv-00203, ILN/1:22-cv-00204, ILN/1:22-cv-00232, ILN/1:22-cv-00239, ILS/3:21-cv-01703, LAM/3:21-cv-00687 (TF)
January 19, 2022 Filing 1 MDL Number 3026 Assigned -- MOTION FOR TRANSFER ACCEPTED FOR FILING re: pldg. ( #1 in Pending No. 62) Associated Cases: Pending No. 62, CAC/2:21-cv-09932, CAC/5:21-cv-00481, CAC/5:21- cv-02145, CAC/5:21-cv-02146, CT/3:20-cv-01626, DC/1:20-cv-02537, FLM/6:21-cv-00502, FLN/1:21-cv-00201, ILN/1:22-cv-00071, ILN/1:22-cv-00192, ILN/1:22-cv-00197, ILN/1:22-cv-00203, ILN/1:22-cv-00204, ILN/1:22-cv-00232, ILN/1:22-cv-00239, ILS/3:21-cv-01703, LAM/3:21-cv-00687 (TF)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Judicial Panel on Multidistrict Litigation's Electronic Court Filings (ECF) System

Search for this case: Monzon v. Abbott Laboratories
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Monzon
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Randi Monzon
Represented By: James G. Onder
Represented By: W. Jason Rankin
Represented By: William Wylie Blair
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Abbott Laboratories
Represented By: Bridget Kathleen O'Connor
Represented By: Bryce Allen Cooper
Represented By: Linda T Coberly
Represented By: Meir Feder
Represented By: Stephanie E Parker
Represented By: Stephen V. D'Amore
Represented By: Scott M Ahmad
Represented By: W. Jason Rankin
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?